Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima Sells 20,000 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $51.15, for a total transaction of $1,023,000.00. Following the sale, the chief operating officer now directly owns 924,460 shares of the company’s stock, valued at approximately $47,286,129. This trade represents a 2.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Ryan Fukushima also recently made the following trade(s):

• On Wednesday, February 19th, Ryan Fukushima sold 2,868 shares of Tempus AI stock. The stock was sold at an average price of $81.87, for a total transaction of $234,803.16.
• On Tuesday, February 4th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $62.50, for a total transaction of $1,250,000.00.
• On Tuesday, January 7th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The stock was sold at an average price of $39.61, for a total transaction of $792,200.00.
• On Monday, December 16th, Ryan Fukushima sold 3,500 shares of Tempus AI stock. The stock was sold at an average price of $40.23, for a total transaction of $140,805.00.
• On Wednesday, December 11th, Ryan Fukushima sold 120,000 shares of Tempus AI stock. The stock was sold at an average price of $42.51, for a total transaction of $5,101,200.00.

Tempus AI Stock Down 7.9 %

Tempus AI stock opened at $48.86 on Friday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm has a 50-day moving average of $53.75 and a 200-day moving average of $52.57. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $91.45.

Institutional Trading of Tempus AI

A number of institutional investors have recently modified their holdings of the company. Wells Fargo & Company MN boosted its holdings in shares of Tempus AI by 13.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock worth $80,000 after purchasing an additional 278 shares during the period. First Horizon Advisors Inc. bought a new position in Tempus AI in the third quarter worth about $30,000. Geode Capital Management LLC raised its stake in Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after buying an additional 539 shares in the last quarter. Operose Advisors LLC bought a new position in Tempus AI in the fourth quarter worth about $25,000. Finally, Prestige Wealth Management Group LLC raised its stake in Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares in the last quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on TEM shares. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. William Blair restated a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. JPMorgan Chase & Co. cut Tempus AI from an “overweight” rating to a “neutral” rating and boosted their price objective for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Morgan Stanley upped their price target on Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, Bank of America upped their price target on Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a research report on Monday. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $61.18.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.